François Dreyfus

18.2k citations

126 papers · 6.2k indexed · h-index 42

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 103
- Acute Myeloid Leukemia Research 78
- Multiple Myeloma Research and Treatments 28
- Hematopoietic Stem Cell Transplantation 15
- Chronic Myeloid Leukemia Treatments 12
Genetics 58
- Myeloproliferative Neoplasms: Diagnosis and Treatment 25
- Chronic Lymphocytic Leukemia Research 23
- Hemoglobinopathies and Related Disorders 16

Co-authors: Didier Bouscary Pierre Fenaux Patrick Mayeux Sophie Park Catherine Lacombe Michaëla Fontenay Norbert Ifrah Norbert Vey
Journals: Blood (53 papers)Leukemia (12 papers)Leukemia Research (11 papers)British Journal of Haematology (8 papers)Journal of Clinical Oncology (6 papers)
Partner nations: France Belgium United States

In The Last Decade

François Dreyfus

123 papers receiving 6.1k citations

Peers

Countries citing papers authored by François Dreyfus

Since Specialization

Citations

This map shows the geographic impact of François Dreyfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Dreyfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Dreyfus more than expected).

Fields of papers citing papers by François Dreyfus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Dreyfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Dreyfus. The network helps show where François Dreyfus may publish in the future.

Co-authors

The 25 scholars most cited alongside François Dreyfus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with François Dreyfus Line = papers co-authored together François Dreyfus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes Leukemia ·S. Mathis, Nicolas Chapuis, Camille Debord, Alexandra Rouquette, I Radford-Weiss, Sophie Park, François Dreyfus, C. Lacombe, Marie C. Béné, Olivier Kosmider, Michaëla Fontenay, Valérie Bardet	2013	58
2	Bortezomib combined with low‐dose cytarabine in Intermediate‐2 and high risk myelodysplastic syndromes. A phase I / II Study by the GFM British Journal of Haematology ·Shanti Natarajan‐Amé, Sophie Park, Lionel Adès, Norbert Vey, Agnès Guerci‐Bresler, Jean‐Yves Cahn, Gabriel Étienne, Dominique Bordessoule, Christophe Ravoet, Laurence Legros, Stéphane Chèze, Aspasia Stamatoullas, É. Berger, Aline Schmidt, Aude Charbonnier, Marie‐Pierre Chaury, Thorsten Braun, Pierre Fenaux, François Dreyfus, (unknown)	2012	12
3	TET2 mutations in secondary acute myeloid leukemias: a French retrospective study Haematologica ·Olivier Kosmider, Éric Delabesse, Véronique Mansat‐De Mas, Pascale Cornillet‐Lefèbvre, Odile Blanchet, Alain Delmer, C. Récher, Stéphane Raynaud, Didier Bouscary, F Viguié, C. Lacombe, Olivier Bernard, Norbert Ifrah, François Dreyfus, Michaëla Fontenay, (unknown)	2011	31
4	Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS Journal of Clinical Oncology ·Arnaud Pigneux, Jean‐Luc Harousseau, Francis Witz, Mathieu Sauvezie, Marie C. Béné, Isabelle Luquet, Mathilde Hunault, Christian Récher, Bruno Lioure, Chantal Himberlin, Martine Escoffre‐Barbe, Christian Berthou, Séverine Lissandre, Nathalie Fegueux, Jean‐Yves Cahn, Éric Jourdan, François Dreyfus, Josy Reiffers, Nöel Milpied, Norbert Ifrah	2010	26
5	Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia Clinical Cancer Research ·Nicolas Chapuis, Jérôme Tamburini, Alexa S. Green, Christine Vignon, Valérie Bardet, Aymeric Neyret, Mélanie Pannetier, Lise Willems, Sophie Park, Alexandre Macone, Sauveur-Michel Maira, Norbert Ifrah, François Dreyfus, Olivier Hérault, Catherine Lacombe, Patrick Mayeux, Didier Bouscary	2010	128
6	Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM Leukemia Research ·Christian Rosé, Sabine Bréchignac, D. Vassilief, Laurent Pascal, Aspasia Stamatoullas, Agnès Guerci, Dalila Larbaa, François Dreyfus, Odile Beyne‐Rauzy, Marie Pierre Chaury, Lydie Roy, Stéphane Chèze, Pierre Morel, Pierre Fenaux	2010	144
7	Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody Haematologica ·Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet‐Lefèbvre, L. Gillot, Valérie Bardet, Lise Willems, Sophie Park, Alexa S. Green, Norbert Ifrah, François Dreyfus, Patrick Mayeux, C. Lacombe, Didier Bouscary	2009	113
8	Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study Blood ·Lionel Adès, Simone Boehrer, Thomas Prébet, Odile Beyne‐Rauzy, Laurence Legros, Christophe Ravoet, François Dreyfus, Aspasia Stamatoullas, Marie Pierre Chaury, Jacques Delaunay, Laurent Guy, Norbert Vey, Sara Burcheri, Rose-Marie Mbida, Natacha Hoarau, Claude Gardin, Pierre Fenaux	2008	107
9	Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients Blood ·Jérôme Tamburini, Caroline Elie, Valérie Bardet, Nicolas Chapuis, Sophie Park, Philippe Broët, Pascale Cornillet‐Lefèbvre, Bruno Lioure, Valérie Ugo, Odile Blanchet, Norbert Ifrah, Francis Witz, François Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary	2007	112
10	A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des Myélodysplasies British Journal of Haematology ·Didier Bouscary, Laurence Legros, M Tulliez, Stéphanie Dubois, Beatrice Mahé, Odile Beyne‐Rauzy, Marie Catherine Quarre, D. Vassilief, Bruno Varet, Achille Aouba, Martine Gardembas, Stéphane Giraudier, Agnès Guerci, Philippe Rousselot, Fanny Gaillard, Philippe Moreau, Marie Christine Rousselet, Norbert Ifrah, Pierre Fenaux, François Dreyfus, (unknown)	2005	37
11	Autoimmune Pancytopenia as an Early Complication of Liver Transplantation : Report of One Case Leukemia & lymphoma ·Charikleia Kelaïdi, Alexandru Buturuga, B. Dousset, Yvon Calmus, François Dreyfus, Didier Bouscary	2004	2
12	Ga-67 in Castleman’s Disease Clinical Nuclear Medicine ·Jean‐Louis Alberini, P. Blanche, Florence Tenenbaum, Annabelle Merlat-Guitard, Jean‐Yves Devaux, François Dreyfus, Didier Sicard, Bruno Richard	2003	1
13	Isodicentric/pseudoisodicentric chromosome 21 amplification in four cases of acute myelocytic leukemia or myelodysplasia Cancer Genetics and Cytogenetics ·F Viguié, Azzedine Aboura, Didier Bouscary, Martine Guesnu, E. Baumelou, François Dreyfus, Nicole Casadevall, Gérard Tachdjian	2002	7
14	Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma Oncogene ·Frédéric Pène, Yann-Érick Claessens, O. Müller, F Viguié, Patrick Mayeux, François Dreyfus, Catherine Lacombe, Didier Bouscary	2002	259
15	hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG Oncogene ·Africa Domı́nguez, Francisco Ramos‐Morales, Francisco Romero, Rosa M. Rı́os, François Dreyfus, Marı́a Tortolero, José A. Pintor‐Toro	1998	167
16	Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias PubMed ·Michaëla Fontenay, Didier Bouscary, J Melle, F Viguié, Françoise Picard, Martine Guesnu, François Dreyfus	1997	21
17	Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients Leukemia ·André Delannoy, Catherine Sebban, Pascale Cony‐Makhoul, Bruno Cazin, Catherine Cordonnier, Réda Bouabdallah, J Cahn, François Dreyfus, Alain Sadoun, Vernant Jp, Caroline Gay, A Broustet, Jl. Michaux, D Fière	1997	25
18	Timed sequential chemotherapy for advanced acute myeloid leukemia PubMed ·E Archimbaud, V. Leblond, Pierre Fenaux, Hervé Dombret, C. Cordonnier, François Dreyfus, Pascale Cony‐Makhoul, Hervé Tilly, Xavier Troussard, G Auzanneau, Xavier Thomas, Martine Ffrench, J. P. Marie	1996	13
19	Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa New England Journal of Medicine ·Olivier Hermine, Didier Bouscary, Antoine Gessain, Pascal Turlure, Véronique Leblond, Nathalie Franck, Agnès Buzyn‐Veil, Bernard Rio, Elisabeth Macintyre, François Dreyfus, Ali Bazarbachi	1995	207
20	Hemodialysis for acute renal failure in patients with hematologic malignancies Critical Care Medicine ·J. J. Lanore, Fabrice Brunet, Frédéric Pochard, Frank Bellivier, Jean-François Dhainaut, JEAN-FRANÇOIS VAXELAIRE, T Giraud, François Dreyfus, Didier Dreyfuss, Jean‐Daniel Chiche, JULIEN-FRANÇOIS MONSALLIER	1991	44

About François Dreyfus

François Dreyfus is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 126 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (78 papers), Multiple Myeloma Research and Treatments (28 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers), Chronic Lymphocytic Leukemia Research (23 papers), Hemoglobinopathies and Related Disorders (16 papers), Hematopoietic Stem Cell Transplantation (15 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (1.6k citations), Molecular Biology (3.0k citations), Oncology (1.0k citations) and Immunology (721 citations). François Dreyfus has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Didier Bouscary, Pierre Fenaux, Patrick Mayeux, Sophie Park, Catherine Lacombe, Michaëla Fontenay, Norbert Ifrah, Norbert Vey, Valérie Bardet and Jérôme Tamburini. Their work appears in journals such as Blood, Leukemia, Leukemia Research, British Journal of Haematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact